49 results on '"Pearson, Jaclyn S."'
Search Results
2. Murine norovirus infection of macrophages induces intrinsic apoptosis as the major form of programmed cell death
- Author
-
Deerain, Joshua M., Aktepe, Turgut E., Trenerry, Alice M., Ebert, Gregor, Hyde, Jennifer L., Charry, Katelyn, Edgington-Mitchell, Laura, Xu, Banyan, Ambrose, Rebecca L., Sarvestani, Soroush T., Lawlor, Kate E., Pearson, Jaclyn S., White, Peter A., and Mackenzie, Jason M.
- Published
- 2024
- Full Text
- View/download PDF
3. Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death
- Author
-
Frank, Daniel, Garnish, Sarah E., Sandow, Jarrod J., Weir, Ashley, Liu, Lin, Clayer, Elise, Meza, Lizeth, Rashidi, Maryam, Cobbold, Simon A., Scutts, Simon R., Doerflinger, Marcel, Anderton, Holly, Lawlor, Kate E., Lalaoui, Najoua, Kueh, Andrew J., Eng, Vik Ven, Ambrose, Rebecca L., Herold, Marco J., Samson, Andre L., Feltham, Rebecca, Murphy, James M., Ebert, Gregor, Pearson, Jaclyn S., and Vince, James E.
- Published
- 2022
- Full Text
- View/download PDF
4. In vivo studies on Citrobacter rodentium and host cell death pathways
- Author
-
Eng, Vik Ven and Pearson, Jaclyn S
- Published
- 2021
- Full Text
- View/download PDF
5. The diverse roles of RIP kinases in host-pathogen interactions
- Author
-
Eng, Vik Ven, Wemyss, Madeleine A., and Pearson, Jaclyn S.
- Published
- 2021
- Full Text
- View/download PDF
6. Evolutionary dynamics of multidrug resistant Salmonella enterica serovar 4,[5],12:i:- in Australia
- Author
-
Ingle, Danielle J., Ambrose, Rebecca L., Baines, Sarah L., Duchene, Sebastian, Gonçalves da Silva, Anders, Lee, Darren Y. J., Jones, Miriam, Valcanis, Mary, Taiaroa, George, Ballard, Susan A., Kirk, Martyn D., Howden, Benjamin P., Pearson, Jaclyn S., and Williamson, Deborah A.
- Published
- 2021
- Full Text
- View/download PDF
7. The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it for proteasomal degradation
- Author
-
Vijayaraj, Swarna L., Feltham, Rebecca, Rashidi, Maryam, Frank, Daniel, Liu, Zhengyang, Simpson, Daniel S., Ebert, Gregor, Vince, Angelina, Herold, Marco J., Kueh, Andrew, Pearson, Jaclyn S., Dagley, Laura F., Murphy, James M., Webb, Andrew I., Lawlor, Kate E., and Vince, James E.
- Published
- 2021
- Full Text
- View/download PDF
8. A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation.
- Author
-
Speir, Mary, Tye, Hazel, Gottschalk, Timothy A, Simpson, Daniel S, Djajawi, Tirta M, Deo, Pankaj, Ambrose, Rebecca L, Conos, Stephanie A, Emery, Jack, Abraham, Gilu, Pascoe, Ashlyn, Hughes, Sebastian A, Weir, Ashley, Hawkins, Edwin D, Kong, Isabella, Herold, Marco J, Pearson, Jaclyn S, Lalaoui, Najoua, Naderer, Thomas, and Vince, James E
- Abstract
Programmed cell death pathways play an important role in innate immune responses to infection. Activation of intrinsic apoptosis promotes infected cell clearance; however, comparatively little is known about how this mode of cell death is regulated during infections and whether it can induce inflammation. Here, we identify that the pro‐survival BCL‐2 family member, A1, controls activation of the essential intrinsic apoptotic effectors BAX/BAK in macrophages and monocytes following bacterial lipopolysaccharide (LPS) sensing. We show that, due to its tight transcriptional and post‐translational regulation, A1 acts as a molecular rheostat to regulate BAX/BAK‐dependent apoptosis and the subsequent NLRP3 inflammasome‐dependent and inflammasome‐independent maturation of the inflammatory cytokine IL‐1β. Furthermore, induction of A1 expression in inflammatory monocytes limits cell death modalities and IL‐1β activation triggered by Neisseria gonorrhoeae‐derived outer membrane vesicles (NOMVs). Consequently, A1‐deficient mice exhibit heightened IL‐1β production in response to NOMV injection. These findings reveal that bacteria can induce A1 expression to delay myeloid cell death and inflammatory responses, which has implications for the development of host‐directed antimicrobial therapeutics. Synopsis: Cell death and inflammatory signalling crosstalk is critical for innate immune responses to pathogens. This study identifies the BCL‐2 family member A1 as a temporal regulator of these processes in myeloid cells upon bacterial recognition. LPS‐induced A1 expression in macrophages and monocytes delays apoptosis and NLRP3 inflammasome activation.Monocyte survival upon pathogen sensing is regulated by the short‐lived pro‐survival proteins MCL‐1 and A1.A1‐deficient myeloid cells can engage necroptotic signalling when apoptotic caspase activity is compromised.A1‐deficiency enhances IL‐1β responses to Neisseria gonorrhoeae‐derived outer membrane vesicles (NOMVs). [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Speaking the host language: how Salmonella effector proteins manipulate the host
- Author
-
Pillay, Timesh D, Hettiarachchi, Sahampath U, Gan, Jiyao, Diaz-Del-Olmo, Ines, Yu, Xiu-Jun, Muench, Janina H, Thurston, Teresa LM, and Pearson, Jaclyn S
- Subjects
Chemical Biology & High Throughput ,Signalling & Oncogenes ,FOS: Clinical medicine ,Immunology ,Infectious Disease ,Biochemistry & Proteomics ,Structural Biology & Biophysics - Abstract
Salmonella injects over 40 virulence factors, termed effectors, into host cells to subvert diverse host cellular processes. Of these 40 Salmonella effectors, at least 25 have been described as mediating eukaryotic-like, biochemical post-translational modifications (PTMs) of host proteins, altering the outcome of infection. The downstream changes mediated by an effector’s enzymatic activity range from highly specific to multifunctional, and altogether their combined action impacts the function of an impressive array of host cellular processes, including signal transduction, membrane trafficking, and both innate and adaptive immune responses. Salmonella and related Gram-negative pathogens have been a rich resource for the discovery of unique enzymatic activities, expanding our understanding of host signalling networks, bacterial pathogenesis as well as basic biochemistry. In this review, we provide an up-to- date assessment of host manipulation mediated by the Salmonella type III secretion system injectosome, exploring the cellular effects of diverse effector activities with a particular focus on PTMs and the implications for infection outcomes. We also highlight activities and functions of numerous effectors that remain poorly characterized.
- Published
- 2023
10. Inhibition of death receptor signaling by bacterial gut pathogens
- Author
-
Giogha, Cristina, Lung, Tania Wong Fok, Pearson, Jaclyn S., and Hartland, Elizabeth L.
- Published
- 2014
- Full Text
- View/download PDF
11. Caspase‐8‐driven apoptotic and pyroptotic crosstalk causes cell death and IL‐1β release in X‐linked inhibitor of apoptosis (XIAP) deficiency.
- Author
-
Hughes, Sebastian A, Lin, Meng, Weir, Ashley, Huang, Bing, Xiong, Liya, Chua, Ngee Kiat, Pang, Jiyi, Santavanond, Jascinta P, Tixeira, Rochelle, Doerflinger, Marcel, Deng, Yexuan, Yu, Chien‐Hsiung, Silke, Natasha, Conos, Stephanie A, Frank, Daniel, Simpson, Daniel S, Murphy, James M, Lawlor, Kate E, Pearson, Jaclyn S, and Silke, John
- Subjects
CELL death ,CROHN'S disease ,APOPTOSIS ,INFLAMMATORY bowel diseases ,MUCOUS membranes ,NLRP3 protein - Abstract
Genetic lesions in X‐linked inhibitor of apoptosis (XIAP) pre‐dispose humans to cell death–associated inflammatory diseases, although the underlying mechanisms remain unclear. Here, we report that two patients with XIAP deficiency–associated inflammatory bowel disease display increased inflammatory IL‐1β maturation as well as cell death–associated caspase‐8 and Gasdermin D (GSDMD) processing in diseased tissue, which is reduced upon patient treatment. Loss of XIAP leads to caspase‐8‐driven cell death and bioactive IL‐1β release that is only abrogated by combined deletion of the apoptotic and pyroptotic cell death machinery. Namely, extrinsic apoptotic caspase‐8 promotes pyroptotic GSDMD processing that kills macrophages lacking both inflammasome and apoptosis signalling components (caspase‐1, ‐3, ‐7, ‐11 and BID), while caspase‐8 can still cause cell death in the absence of both GSDMD and GSDME when caspase‐3 and caspase‐7 are present. Neither caspase‐3 and caspase‐7‐mediated activation of the pannexin‐1 channel, or GSDMD loss, prevented NLRP3 inflammasome assembly and consequent caspase‐1 and IL‐1β maturation downstream of XIAP inhibition and caspase‐8 activation, even though the pannexin‐1 channel was required for NLRP3 triggering upon mitochondrial apoptosis. These findings uncouple the mechanisms of cell death and NLRP3 activation resulting from extrinsic and intrinsic apoptosis signalling, reveal how XIAP loss can co‐opt dual cell death programs, and uncover strategies for targeting the cell death and inflammatory pathways that result from XIAP deficiency. Synopsis: XIAP deficiency causes hemophagocytic lymphohistiocytosis and Crohn's disease. Analysis of XIAP‐deficient patients and cellular studies show that apoptotic caspases and GSDMD act redundantly downstream of caspase‐8 to cause excess cell death and IL‐1β release. XIAP deficiency increases cleaved caspase‐8 and GSDMD in mucosal tissue and cellsCrosstalk in apoptosis and pyroptosis sensitises cells to caspase‐8‐driven death and IL‐1β activation upon XIAP inhibitionPannexin‐1 and GSDMD are dispensable for NLRP3 inflammasome formation downstream of caspase‐8Pannexin‐1 cleavage by caspase‐3 and caspase‐7 is required for efficient NLRP3 activation following intrinsic apoptosis [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. A type III effector antagonizes death receptor signalling during bacterial gut infection
- Author
-
Pearson, Jaclyn S., Giogha, Cristina, Ong, Sze Ying, Kennedy, Catherine L., Kelly, Michelle, Robinson, Keith S., Lung, Tania Wong Fok, Mansell, Ashley, Riedmaier, Patrice, Oates, Clare V.L., Zaid, Ali, Muhlen, Sabrina, Crepin, Valerie F., Marches, Olivier, Ang, Ching-Seng, Williamson, Nicholas A., O'Reilly, Lorraine A., Bankovacki, Aleksandra, Nachbur, Ueli, Infusini, Giuseppe, Webb, Andrew I., Silke, John, Strasser, Andreas, Frankel, Gad, and Hartland, Elizabeth L.
- Subjects
Stomach diseases -- Physiological aspects ,Bacterial infections -- Research ,Microbiology -- Research ,Cell receptors -- Physiological aspects ,Pathogenic microorganisms -- Physiological aspects ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Successful infection by enteric bacterial pathogens depends on the ability of the bacteria to colonize the gut, replicate in host tissues and disseminate to other hosts. Pathogens such as Salmonella, Shigella and enteropathogenic and enterohaemorrhagic (EPEC and EHEC, respectively) Escherichia coli use a type III secretion system (T3SS) to deliver virulence effector proteins into host cells during infection that promote colonization and interfere with antimicrobial host responses (1-3). Here we report that the T3SS effector NleB1 from EPEC binds to host cell death-domain-containing proteins and thereby inhibits death receptor signalling. Protein interaction studies identified FADD, TRADD and RIPK1 as binding partners of NleB1. NleB1 expressed ectopically or injected by the bacterial T3SS prevented Fas ligand or TNF-induced formation of the canonical death-inducing signalling complex (DISC) and proteolytic activation of caspase-8, an essential step in death-receptor-induced apoptosis. This inhibition depended on the N-acetylglucosamine transferase activity of NleB1, which specifically modified Arg 117 in the death domain of FADD. The importance of the death receptor apoptotic pathway to host defence was demonstrated using mice deficient in the FAS signalling pathway, which showed delayed clearance of the EPEC-like mouse pathogen Citrobacter rodentium and reversion to virulence of an nleB mutant. The activity of NleB suggests that EPEC and other attaching and effacing pathogens antagonize death-receptor-induced apoptosis of infected cells, thereby blocking a major antimicrobial host response., Members of the death receptor family such as FAS and TNFR1 contain an intracellular death domain and require caspase-8 for the activation of effector caspases and consequent cell death by [...]
- Published
- 2013
13. Evolution of atypical enteropathogenic E. coli by repeated acquisition of LEE pathogenicity island variants
- Author
-
Ingle, Danielle J., Tauschek, Marija, Edwards, David J., Hocking, Dianna M., Pickard, Derek J., Azzopardi, Kristy I., Amarasena, Thakshila, Bennett-Wood, Vicki, Pearson, Jaclyn S., Tamboura, Boubou, Antonio, Martin, Ochieng, John B., Oundo, Joseph, Mandomando, Inácio, Qureshi, Shahida, Ramamurthy, Thandavarayan, Hossain, Anowar, Kotloff, Karen L., Nataro, James P., Dougan, Gordon, Levine, Myron M., Robins-Browne, Roy M., and Holt, Kathryn E.
- Published
- 2016
- Full Text
- View/download PDF
14. Targeting of microvillus protein Eps8 by the NleH effector kinases from enteropathogenic E. coli.
- Author
-
Pollock, Georgina L., Grishin, Andrey M., Giogha, Cristina, Jiyao Gan, Oates, Clare V., McMillan, Paul J., Gaeta, Isabella, Tyska, Matthew J., Pearson, Jaclyn S., Scott, Nichollas E., Cygler, Miroslaw, and Hartland, Elizabeth L.
- Subjects
ESCHERICHIA coli ,MICROVILLI ,KINASES ,PEPTIDES ,PROTEINS - Abstract
Attaching and effacing (AE) lesion formation on enterocytes by enteropathogenic Escherichia coli (EPEC) requires the EPEC type III secretion system (T3SS). Two T3SS effectors injected into the host cell during infection are the atypical kinases, NleH1 and NleH2. However, the host targets of NleH1 and NleH2 kinase activity during infection have not been reported. Here phosphoproteomics identified Ser775 in the microvillus protein Eps8 as a bona fide target of NleH1 and NleH2 phosphorylation. Both kinases interacted with Eps8 through previously unrecognized, noncanonical "proline-rich" motifs, PxxDY, that bound the Src Homology 3 (SH3) domain of Eps8. Structural analysis of the Eps8 SH3 domain bound to a peptide containing one of the proline-rich motifs from NleH showed that the N-terminal part of the peptide adopts a type II polyproline helix, and its C-terminal "DY" segment makes multiple contacts with the SH3 domain. Ser775 phosphorylation by NleH1 or NleH2 hindered Eps8 bundling activity and drove dispersal of Eps8 from the AE lesion during EPEC infection. This finding suggested that NleH1 and NleH2 altered the cellular localization of Eps8 and the cytoskeletal composition of AE lesions during EPEC infection. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements
- Author
-
Wong, Alexander R. C., Pearson, Jaclyn S., Bright, Michael D., Munera, Diana, Robinson, Keith S., Lee, Sau Fung, Frankel, Gad, and Hartland, Elizabeth L.
- Published
- 2011
- Full Text
- View/download PDF
16. A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation
- Author
-
Pearson, Jaclyn S., Riedmaier, Patrice, Marchès, Olivier, Frankel, Gad, and Hartland, Elizabeth L.
- Published
- 2011
- Full Text
- View/download PDF
17. Shigella shuts down the pyrop-technic show.
- Author
-
Giogha, Cristina and Pearson, Jaclyn S.
- Abstract
Shigella is a highly infectious human pathogen, yet mice are naturally resistant to infection. In this issue of Cell Host & Microbe , Luchetti et al. (2021) discuss this species specificity, demonstrating that Shigella directly targets the pore-forming protein Gasdermin D for degradation, thus preventing pyroptosis to enable infection of human cells. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. Editorial: Bacterial Effectors as Drivers of Human Disease: Models, Methods, Mechanisms.
- Author
-
Schroeder, Gunnar N., Pearson, Jaclyn S., and Thurston, Teresa L. M.
- Subjects
PORPHYROMONAS gingivalis ,NUTRITION - Abstract
Effectors, bacterial pathogenesis, virulence factors, host-pathogen interactions, secretion systems Understanding the specific roles of effectors in pathogenesis requires not only target identification and biochemical characterisation, but also consideration of how and when the secretion system and effectors are expressed. Keywords: effectors; bacterial pathogenesis; virulence factors; host-pathogen interactions; secretion systems EN effectors bacterial pathogenesis virulence factors host-pathogen interactions secretion systems 1 4 4 07/12/21 20210708 NES 210708 Introduction Bacteria colonise virtually all ecological niches on earth. T3SS Effectors - Injected Munition for Host Subversion by Enteric Pathogens and Beyond A wide variety of human and environmental pathogens employ T3SSs to translocate effectors in one step from the bacteria into the host cytoplasm ([5]). [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
19. Sequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2′-O-methyl gapmer oligonucleotides.
- Author
-
Valentin, Roxane, Wong, Christophe, Alharbi, Arwaf S, Pradeloux, Solène, Morros, Makala P, Lennox, Kim A, Ellyard, Julia I, Garcin, Aurélie J, Ullah, Tomalika R, Kusuma, Gina D, Pépin, Geneviève, Li, Hong-Mei, Pearson, Jaclyn S, Ferrand, Jonathan, Lim, Rebecca, Veedu, Rakesh N, Morand, Eric F, Vinuesa, Carola G, Behlke, Mark A, and Gantier, Michael P
- Published
- 2021
- Full Text
- View/download PDF
20. NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector.
- Author
-
Giogha, Cristina, Scott, Nichollas E., Wong Fok Lung, Tania, Pollock, Georgina L., Harper, Marina, Goddard-Borger, Ethan D., Pearson, Jaclyn S., and Hartland, Elizabeth L.
- Subjects
GALACTOSE ,ESCHERICHIA coli ,POST-translational modification ,AMINO acid residues ,AMINO acid sequence ,BINDING site assay ,GLUCOSE - Abstract
During infection, enteropathogenic Escherichia coli (EPEC) and enterohaemorrhagic E. coli (EHEC) directly manipulate various aspects of host cell function through the translocation of type III secretion system (T3SS) effector proteins directly into the host cell. Many T3SS effector proteins are enzymes that mediate post-translational modifications of host proteins, such as the glycosyltransferase NleB1, which transfers a single N-acetylglucosamine (GlcNAc) to arginine residues, creating an Arg-GlcNAc linkage. NleB1 glycosylates death-domain containing proteins including FADD, TRADD and RIPK1 to block host cell death. The NleB1 paralogue, NleB2, is found in many EPEC and EHEC strains but to date its enzymatic activity has not been described. Using in vitro glycosylation assays combined with mass spectrometry, we found that NleB2 can utilize multiple sugar donors including UDP-glucose, UDP-GlcNAc and UDP-galactose during glycosylation of the death domain protein, RIPK1. Sugar donor competition assays demonstrated that UDP-glucose was the preferred substrate of NleB2 and peptide sequencing identified the glycosylation site within RIPK1 as Arg603, indicating that NleB2 catalyses arginine glucosylation. We also confirmed that NleB2 catalysed arginine-hexose modification of Flag-RIPK1 during infection of HEK293T cells with EPEC E2348/69. Using site-directed mutagenesis and in vitro glycosylation assays, we identified that residue Ser252 in NleB2 contributes to the specificity of this distinct catalytic activity. Substitution of Ser252 in NleB2 to Gly, or substitution of the corresponding Gly255 in NleB1 to Ser switches sugar donor preference between UDP-GlcNAc and UDP-glucose. However, this switch did not affect the ability of the NleB variants to inhibit inflammatory or cell death signalling during HeLa cell transfection or EPEC infection. NleB2 is thus the first identified bacterial Arg-glucose transferase that, similar to the NleB1 Arg-GlcNAc transferase, inhibits host protein function by arginine glycosylation. Author summary: Bacterial gut pathogens including enteropathogenic E. coli (EPEC) and enterohaemorrhagic E. coli (EHEC), manipulate host cell function by using a type III secretion system to inject 'effector' proteins directly into the host cell cytoplasm. We and others have shown that many of these effectors are novel enzymes, including NleB1, which transfers a single N-acetylglucosamine (GlcNAc) sugar to arginine residues, mediating Arg-GlcNAc glycosylation. Here, we found that a close homologue of NleB1 that is also present in EPEC and EHEC termed NleB2, uses a different sugar during glycosylation. We demonstrated that in contrast to NleB1, the preferred nucleotide-sugar substrate of NleB2 is UDP-glucose and we identified the amino acid residue within NleB2 that dictates this unique catalytic activity. Substitution of this residue in NleB2 and NleB1 switches the sugar donor usage of these enzymes but does not affect their ability to inhibit host cell signalling. Thus, NleB2 is the first identified bacterial arginine-glucose transferase, an activity which has previously only been described in plants and algae. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. An acetate‐yielding diet imprints an immune and anti‐microbial programme against enteric infection.
- Author
-
Yap, Yu Anne, McLeod, Keiran H, McKenzie, Craig I, Gavin, Patrick G, Davalos‐Salas, Mercedes, Richards, James L, Moore, Robert J, Lockett, Trevor J, Clarke, Julie M, Eng, Vik Ven, Pearson, Jaclyn S, Hamilton‐Williams, Emma E, Mackay, Charles R, and Mariño, Eliana
- Subjects
INTESTINAL infections ,SHORT-chain fatty acids ,G protein coupled receptors ,ANIMAL nutrition ,CARBOHYDRATE metabolism - Abstract
Objectives: During gastrointestinal infection, dysbiosis can result in decreased production of microbially derived short‐chain fatty acids (SCFAs). In response to the presence of intestinal pathogens, we examined whether an engineered acetate‐ or butyrate‐releasing diet can rectify the deficiency of SCFAs and lead to the resolution of enteric infection. Methods: We tested whether a high acetate‐ or butyrate‐producing diet (HAMSA or HAMSB, respectively) condition Citrobacterrodentium infection in mice and assess its impact on host‐microbiota interactions. We analysed the adaptive and innate immune responses, changes in gut microbiome function, epithelial barrier function and the molecular mechanism via metabolite sensing G protein‐coupled receptor 43 (GPR43) and IL‐22 expression. Results: HAMSA diet rectified the deficiency in acetate production and protected against enteric infection. Increased SCFAs affect the expression of pathogen virulence genes. HAMSA diet promoted compositional and functional changes in the gut microbiota during infection similar to healthy microbiota from non‐infected mice. Bacterial changes were evidenced by the production of proteins involved in acetate utilisation, starch and sugar degradation, amino acid biosynthesis, carbohydrate transport and metabolism. HAMSA diet also induced changes in host proteins critical in glycolysis, wound healing such as GPX1 and epithelial architecture such as EZR1 and PFN1. Dietary acetate assisted in rapid epithelial repair, as shown by increased colonic Muc‐2, Il‐22, and anti‐microbial peptides. We found that acetate increased numbers of colonic IL‐22 producing TCRαβ+CD8αβ+ and TCRγδ+CD8αα+ intraepithelial lymphocytes expressing GPR43. Conclusion: HAMSA diet may be an effective therapeutic approach for fighting inflammation and enteric infections and offer a safe alternative that may impact on human health. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. The Salmonella Effector SseK3 Targets Small Rab GTPases.
- Author
-
Gan, Jiyao, Scott, Nichollas E., Newson, Joshua P. M., Wibawa, Rachelia R., Wong Fok Lung, Tania, Pollock, Georgina L., Ng, Garrett Z., van Driel, Ian, Pearson, Jaclyn S., Hartland, Elizabeth L., and Giogha, Cristina
- Subjects
SALMONELLA diseases ,SALMONELLA ,INTRACELLULAR pathogens ,DEATH receptors ,SALMONELLA enterica ,SECRETION - Abstract
During infection, Salmonella species inject multiple type III secretion system (T3SS) effector proteins into host cells that mediate invasion and subsequent intracellular replication. At early stages of infection, Salmonella exploits key regulators of host intracellular vesicle transport, including the small GTPases Rab5 and Rab7, to subvert host endocytic vesicle trafficking and establish the Salmonella- containing vacuole (SCV). At later stages of intracellular replication, interactions of the SCV with Rab GTPases are less well defined. Here we report that Rab1, Rab5, and Rab11 are modified at later stages of Salmonella infection by SseK3, an arginine N- acetylglucosamine (GlcNAc) transferase effector translocated via the Salmonella pathogenicity island 2 (SPI-2) type III secretion system. SseK3 modified arginines at positions 74, 82, and 111 within Rab1 and this modification occurred independently of Rab1 nucleotide binding. SseK3 exhibited Golgi localization that was independent of its glycosyltransferase activity but Arg-GlcNAc transferase activity was required for inhibition of alkaline phosphatase secretion in transfected cells. While SseK3 had a modest effect on SEAP secretion during infection of HeLa229 cells, inhibition of IL-1 and GM-CSF cytokine secretion was only observed upon over-expression of SseK3 during infection of RAW264.7 cells. Our results suggest that, in addition to targeting death receptor signaling, SseK3 may contribute to Salmonella infection by interfering with the activity of key Rab GTPases. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
23. Fluorescent antibiotics, vomocytosis, vaccine candidates and the inflammasome.
- Author
-
Lundie, Rachel J, Helbig, Karla J, Pearson, Jaclyn S, and Fairfax, Kirsten A
- Subjects
ANTIBIOTICS ,MALARIA ,ANIMAL diseases ,MEDICAL research - Published
- 2019
- Full Text
- View/download PDF
24. Host Cell Death Responses to Non-typhoidal Salmonella Infection.
- Author
-
Wemyss, Madeleine A. and Pearson, Jaclyn S.
- Subjects
SALMONELLA diseases ,SALMONELLA enterica serovar Typhi ,CELL death ,APOPTOSIS ,GASTROINTESTINAL mucosa ,EPITHELIAL cells - Abstract
Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium) is a Gram-negative bacterium with a broad host range that causes non-typhoidal salmonellosis in humans. S. Typhimurium infects epithelial cells and macrophages in the small intestine where it replicates in a specialized intracellular niche called the Salmonella -containing vacuole (SCV) and promotes inflammation of the mucosa to induce typically self-limiting gastroenteritis. Virulence and spread of the bacterium is determined in part by the host individual's ability to limit the infection through innate immune responses at the gastrointestinal mucosa, including programmed cell death. S. Typhimurium however, has evolved a myriad of mechanisms to counteract or exploit host responses through the use of Type III Secretion Systems (T3SS), which allow the translocation of virulence (effector) proteins into the host cell for the benefit of optimal bacterial replication and dissemination. T3SS effectors have been found to interact with apoptotic, necroptotic, and pyroptotic cell death cascades, interfering with both efficient clearance of the bacteria and the recruitment of neutrophils or dendritic cells to the area of infection. The interplay of host inflammation, programmed cell death responses, and bacterial defenses in the context of non-typhoidal Salmonella (NTS) infection is a continuing area of interest within the field, and as such has been reviewed here. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
25. A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation
- Author
-
Pearson, Jaclyn S, Riedmaier, Patrice, Marchès, Olivier, Frankel, Gad, and Hartland, Elizabeth L
- Subjects
Enteropathogenic Escherichia coli ,Microscopy, Confocal ,Escherichia coli Proteins ,Immunoblotting ,Interleukin-8 ,Transcription Factor RelA ,Fluorescent Antibody Technique ,Humans ,GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries) ,Research Articles ,HeLa Cells - Abstract
Many bacterial pathogens utilize a type III secretion system (T3SS) to inject virulence effector proteins into host cells during infection. Previously, we found that enteropathogenic Escherichia coli (EPEC) uses the type III effector, NleE, to block the inflammatory response by inhibiting IκB degradation and nuclear translocation of the p65 subunit of NF-κB. Here we screened further effectors with unknown function for their capacity to prevent p65 nuclear translocation. We observed that ectopic expression of GFP-NleC in HeLa cells led to the degradation of p65. Delivery of NleC by the T3SS of EPEC also induced degradation of p65 in infected cells as well as other NF-κB components, c-Rel and p50. Recombinant His(6) -NleC induced p65 and p50 cleavage in HeLa cell lysates and mutation of a consensus zinc metalloprotease motif, HEIIH, abrogated NleC proteolytic activity. NleC inhibited IL-8 production during prolonged EPEC infection of HeLa cells in a protease activity-dependent manner. A double nleE/nleC mutant was further impaired for its ability to inhibit IL-8 secretion than either a single nleE or a single nleC mutant. We conclude that NleC is a type III effector protease that degrades NF-κB thereby contributing the arsenal of bacterial effectors that inhibit innate immune activation.
- Published
- 2011
26. Down the rabbit hole: Is necroptosis truly an innate response to infection?
- Author
-
Pearson, Jaclyn S. and Murphy, James M.
- Subjects
- *
NECROSIS , *INFECTION risk factors , *PATHOGENIC microorganisms , *IMMUNE response , *APOPTOSIS - Abstract
Pathogenic microbes have evolved countless sophisticated mechanisms to subvert host immune responses and cause disease. Understanding evasion strategies employed by pathogens has led to numerous discoveries on specific host cell processes that are critical for controlling infection. Programmed cell death (PCD) is a key host defence to microbial infection, as well as being critical for organ development and cellular homeostasis in multicellular organisms. Much of our current understanding of PCD as a host response to infection has stemmed from the discovery and study of viral inhibitors of apoptosis, and more recently viral inhibition of the newly characterised from of PCD termed necroptosis, the mechanisms of which are still under intense investigation. Many bacterial pathogens also encode inhibitors of PCD, yet these discoveries are relatively more recent and thus the biological significance of such mechanisms is still under debate. In this viewpoint article, we will argue the concept that necroptosis is merely a 'back-up' mechanism in the event that apoptosis is inhibited, or whether it is a true host innate response to infection that has evolved in response to a growing arsenal of microbial evasion strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
27. The Genetics of Enteropathogenic Escherichia coli Virulence.
- Author
-
Pearson, Jaclyn S., Giogha, Cristina, Wong Fok Lung, Tania, and Hartland, Elizabeth L.
- Abstract
In many parts of the world, enteropathogenic Escherichia coli (EPEC) are a leading cause of death in children with diarrhea. Much of what we know about the pathogenesis of EPEC infections is based on the study of one or two prototypic strains that have provided deep insight into the precise mechanisms by which EPEC colonizes the intestine, evades host immunity, and spreads from person to person. In some cases, defining the biochemical activity of the host-interacting effector proteins from these prototypic strains has led to the discovery of novel post-translational protein modifications and new understandings of biology and host-pathogen interactions. However, genomic analysis of recent EPEC isolates has revealed that the EPEC pathotype is more diverse than previously appreciated. Although by definition all strains carry the locus of enterocyte effacement, the effector repertoires of different clonal groups are quite divergent, suggesting that there is still a great deal to learn about the genetic basis of EPEC virulence. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
28. Substrate recognition by the zinc metalloprotease effector NleC from enteropathogenic E scherichia coli.
- Author
-
Giogha, Cristina, Wong Fok Lung, Tania, Mühlen, Sabrina, Pearson, Jaclyn S., and Hartland, Elizabeth L.
- Subjects
ZINC metallurgy ,METALLOPROTEINASES ,ESCHERICHIA coli diseases ,EPITHELIAL cells ,HOMOLOGY (Biology) ,BACTERIAL proteins ,DISEASES - Abstract
Upon infection of epithelial cells, enteropathogenic E scherichia coli suppresses host cell inflammatory signalling in a type III secretion system ( T3SS) dependent manner. Two key T3SS effector proteins involved in this response are NleE and NleC. NleC is a zinc metalloprotease effector that degrades the p65 subunit of NF- κB. Although the site of p65 cleavage by NleC is now well described, other areas of interaction have not been precisely defined. Here we constructed overlapping truncations of p65 to identify regions required for NleC cleavage. We determined that NleC cleaved both p65 and p50 within the Rel homology domain ( RHD) and that two motifs, E
22 IIE25 and P177 VLS180 , within the RHD of p65 were important for recognition and binding by NleC. Alanine substitution of one or both of these motifs protected p65 from binding and degradation by NleC. The E22 IIE25 and P177 VLS180 motifs were located within the structurally distinct N-terminal subdomain of the RHD involved in DNA binding by p65 on adjacent, parallel strands. Although these motifs have not been recognized previously, both were needed for the correct localization and function of p65. In summary, this work has identified two regions of p65 within the RHD needed for binding and cleavage by NleC and provides further insight into the molecular basis of substrate recognition by a T3SS effector. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
29. Post-modern pathogens: surprising activities of translocated effectors from E. coli and Legionella.
- Author
-
Pearson, Jaclyn S, Zhang, Ying, Newton, Hayley J, and Hartland, Elizabeth L
- Subjects
- *
PATHOGENIC microorganisms , *ESCHERICHIA coli , *LEGIONELLA , *CELL physiology , *BACTERIAL proteins , *GRAM-negative bacteria , *MICROBIAL virulence - Abstract
Many bacterial pathogens have the ability to manipulate cellular processes and interfere with host cell function through the translocation of bacterial ‘effector’ proteins. Dedicated protein secretion machines from Gram-negative pathogens, including type III, type IV and type VI secretion systems, inject virulence proteins into infected cells, altering normal cell physiology, including cell structure, metabolism, trafficking and signalling. While effectors were once thought to exert an effect simply by their localization and binding to host cell proteins, increasingly effectors are being recognised as enzymes, in some cases mediating highly novel post-translational modifications on host proteins. Here we highlight some of the more unusual activities of translocated effectors from enteropathogenic Escherichia coli and Legionella pneumophila . [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
30. The cell death response to enteropathogenic E scherichia coli infection.
- Author
-
Wong Fok Lung, Tania, Pearson, Jaclyn S., Schuelein, Ralf, and Hartland, Elizabeth L.
- Subjects
- *
CELL death , *ESCHERICHIA coli , *DIARRHEA in infants , *INFLAMMATION , *PATHOGENIC microorganisms , *ANTI-infective agents , *HOSTS (Biology) - Abstract
Given the critical roles of inflammation and programmed cell death in fighting infection, it is not surprising that many bacterial pathogens have evolved strategies to inactivate these defences. The causative agent of infant diarrhoea, enteropathogenic E scherichia coli ( EPEC), is an extracellular, intestinal pathogen that blocks both inflammation and programmed cell death. EPEC attaches to enterocytes, remains in the gut lumen and utilizes a type III secretion system ( T3SS) to inject multiple virulence effector proteins directly into the infected cell, many of which subvert host antimicrobial processes through the disruption of signalling pathways. Recently, T3SS effector proteins from EPEC have been identified that inhibit death receptor-induced apoptosis. Here we review the mechanisms used by EPEC T3SS effectors to manipulate apoptosis and promote host cell survival and discuss the role of these activities during infection. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
31. A surprising sweetener from enteropathogenic Escherichia coli.
- Author
-
Pearson, Jaclyn S and Hartland, Elizabeth L
- Published
- 2014
- Full Text
- View/download PDF
32. The Type III Effectors NleE and NleB from Enteropathogenic E. coli and OspZ from Shigella Block Nuclear Translocation of NF-ĸB p65.
- Author
-
Newton, Hayley J., Pearson, Jaclyn S., Badea, Luminita, Kelly, Michelle, Lucas, Mark, Holloway, Gavan, Wagstaff, Kylie M., Dunstone, Michelle A., Sloan, Joan, Whisstock, James C., Kaper, James B., Robins-Browne, Roy M., Jans, David A., Frankel, Gad, Phillips, Alan D., Coulson, Barbara S., and Hartland, Elizabeth L.
- Subjects
- *
PATHOGENIC microorganisms , *SECRETION , *PROTEINS , *ESCHERICHIA coli , *SHIGELLA , *CELL nuclei - Abstract
Many bacterial pathogens utilize a type III secretion system to deliver multiple effector proteins into host cells. Here we found that the type III effectors, NleE from enteropathogenic E. coli (EPEC) and OspZ from Shigella, blocked translocation of the p65 subunit of the transcription factor, NF-κB, to the host cell nucleus. NF-κB inhibition by NleE was associated with decreased IL-8 expression in EPEC-infected intestinal epithelial cells. Ectopically expressed NleE also blocked nuclear translocation of p65 and c-Rel, but not p50 or STAT1/2. NleE homologues from other attaching and effacing pathogens as well OspZ from Shigella flexneri 6 and Shigella boydii, also inhibited NF-κB activation and p65 nuclear import; however, a truncated form of OspZ from S. flexneri 2a that carries a 36 amino acid deletion at the C-terminus had no inhibitory activity. We determined that the C-termini of NleE and full length OspZ were functionally interchangeable and identified a six amino acid motif, IDSY(M/I)K, that was important for both NleE- and OspZ-mediated inhibition of NF-κB activity. We also established that NleB, encoded directly upstream from NleE, suppressed NF-κB activation. Whereas NleE inhibited both TNFa and IL-1β stimulated p65 nuclear translocation and IkB degradation, NleB inhibited the TNFa pathway only. Neither NleE nor NleB inhibited AP-1 activation, suggesting that the modulatory activity of the effectors was specific for NF-κB signaling. Overall our data show that EPEC and Shigella have evolved similar T3SS-dependent means to manipulate host inflammatory pathways by interfering with the activation of selected host transcriptional regulators. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
33. Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death.
- Author
-
Lin Liu, Sandow, Jarrod J., Pedrioli, Deena M. Leslie, Samson, Andre L., Silke, Natasha, Kratina, Tobias, Ambrose, Rebecca L., Doerflinger, Marcel, Zhaoqing Hu, Morrish, Emma, Diep Chau, Kueh, Andrew J., Fitzibbon, Cheree, Pellegrini, Marc, Pearson, Jaclyn S., Hottiger, Michael O., Webb, Andrew I., Lalaoui, Najoua, and Silke, John
- Subjects
- *
CELL death , *DEATH receptors , *DOXYCYCLINE , *LIFE sciences , *ADP-ribosylation , *SARS-CoV-2 , *GREEN fluorescent protein - Abstract
The article presents a study which explores that Tankyrase-mediated ADP-ribosylation, a regulator of Tumor necrosis factor (TNF)-induced death . It mentions that findings of the study suggests that disruption of ADP-ribosylation during an infection can prime a cell to retaliate with an inflammatory cell death.
- Published
- 2022
- Full Text
- View/download PDF
34. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).
- Author
-
Scott, Nichollas E., Giogha, Cristina, Pollock, Georgina L., Kennedy, Catherine L., Webb, Andrew I., Williamson, Nicholas A., Pearson, Jaclyn S., and Hartland, Elizabeth L.
- Subjects
- *
ESCHERICHIA coli , *PATHOGENIC microorganisms , *GRAM-negative bacteria , *CYTOKINES , *TAPEWORMS , *GASTROINTESTINAL diseases , *IMMUNE response - Abstract
The inhibition of host innate immunity pathways is essential for the persistence of attaching and effacing pathogens such as enteropathogenic Escherichia coli (EPEC) and Citrobacter rodentium during mammalian infections. To subvert these pathways and suppress the antimicrobial response, attaching and effacing pathogens use type III secretion systems to introduce effectors targeting key signaling pathways in host cells. One such effector is the arginine glycosyltransferase NleB1 (NleBCR in C. rodentium) that modifies conserved arginine residues in death domain-containing host proteins with N-acetylglucosamine (GlcNAc), thereby blocking extrinsic apoptosis signaling. Ectopically expressed NleB1 modifies the host proteins Fas-associated via death domain (FADD), TNFRSF1A-associated via death domain (TRADD), and receptor-interacting serine/threonine protein kinase 1 (RIPK1). However, the full repertoire of arginine GlcNAcylation induced by pathogen-delivered NleB1 is unknown. Using an affinity proteomic approach for measuring arginine-GlcNAcylated glycopeptides, we assessed the global profile of arginine GlcNAcylation during ectopic expression of NleB1, EPEC infection in vitro, or C. rodentium infection in vivo. NleB overexpression resulted in arginine GlcNAcylation of multiple host proteins. However, NleB delivery during EPEC and C. rodentium infection caused rapid and preferential modification of Arg117 in FADD. This FADD modification was extremely stable and insensitive to physiological temperatures, glycosidases, or host cell degradation. Despite its stability and effect on the inhibition of apoptosis, arginine GlcNAcylation did not elicit any proteomic changes, even in response to prolonged NleB1 expression. We conclude that, at normal levels of expression during bacterial infection, NleB1/NleBCR antagonizes death receptor-induced apoptosis of infected cells by modifying FADD in an irreversible manner. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
35. Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ.
- Author
-
Ying Zhang, Mühlen, Sabrina, Oates, Clare V., Pearson, Jaclyn S., and Hartland, Elizabeth L.
- Subjects
- *
ESCHERICHIA coli , *METHYLTRANSFERASES , *INTERLEUKIN-8 , *PROTEIN-protein interactions , *ADENOSYLMETHIONINE - Abstract
The type III secretion system effector protein NleE from enteropathogenic Escherichia coli plays a key role in the inhibition of NF-κB activation during infection. NleE inactivates the ubiquitin chain binding activity of host proteins TAK1-binding proteins 2 and 3 (TAB2 and TAB3) by modifying the Npl4 zinc finger domain through S-adenosyl methionine-dependent cysteine methylation. Using yeast two-hybrid protein interaction studies, we found that a conserved region between amino acids 34 and 52 of NleE, in particular the motif 49GITR52, was critical for TAB2 and TAB3 binding. NleE mutants lacking 49GITR52 were unable to methylate TAB3, and wild type NleE but not NleE49AAAA52 where each of GITR was replaced with alanine restored the ability of an nleE mutant to inhibit IL-8 production during infection. Another NleE target, ZRANB3, also associated with NleE through the 49GITR52 motif. Ectopic expression of an N-terminal fragment of NleE (NleE34-52) in HeLa cells showed competitive inhibition of wild type NleE in the suppression of IL-8 secretion during enteropathogenic E. coli infection. Similar results were observed for the NleE homologue OspZ from Shigella flexneri 6 that also bound TAB3 through the 49GITR52 motif and decreased IL-8 transcription through modification of TAB3. In summary, we have identified a unique substrate-binding motif in NleE and OspZ that is required for the ability to inhibit the host inflammatory response. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
36. Characterization of the ospZ Promoter in Shigella flexneri and Its Regulation by VirB and H-NS.
- Author
-
Basta, David W., Pew, Krystle L., Immak, Joy A., Park, Hiromichi S., Picker, Michael A., Wigley, Amanda F., Hensley, Christopher T., Pearson, Jaclyn S., Hartland, Elizabeth L., and Wing, Helen J.
- Subjects
- *
SHIGELLA flexneri , *BACTERIAL diseases , *PLASMID genetics , *MICROBIAL virulence , *PATHOGENIC microorganisms - Abstract
OspZ is an effector protein of the type III secretion system in Shigella spp. that downregulates the human inflammatory response during bacterial infection. The ospZ gene is located on the large virulence plasmid of Shigella. Many genes on this plasmid are transcriptionally repressed by the nucleoid structuring protein H-NS and derepressed by VirB, a DNA-binding protein that displays homology to the plasmid partitioning proteins ParB and SopB. In this study, we characterized the ospZ promoter and investigated its regulation by H-NS and VirB in Shigella flexneri. We show that H-NS represses and VirB partially derepresses the ospZ promoter. H-NS-mediated repression requires sequences located between -731 and -412 relative to the beginning of the ospZ gene. Notably, the VirB-dependent derepression of ospZ requires the same VirB binding sites as are required for the VirB-dependent derepression of the divergent icsP gene. These sites are centered 425 bp upstream of the ospZ gene but over 1 kb upstream of the icsP transcription start site. Although these VirB binding sites lie closer to ospZ than icsP, the VirB-dependent increase in ospZ promoter activity is lower than that observed at the icsP promoter. This indicates that the proximity of VirB binding sites to Shigella promoters does not necessarily correlate with the level of VirB-dependent derepression. These findings have implications for virulence gene regulation in Shigella and other pathogens that control gene expression using mechanisms of transcriptional repression and derepression. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
37. Flexible Usage and Interconnectivity of Diverse Cell Death Pathways Protect against Intracellular Infection.
- Author
-
Doerflinger, Marcel, Deng, Yexuan, Whitney, Paul, Salvamoser, Ranja, Engel, Sven, Kueh, Andrew J., Tai, Lin, Bachem, Annabell, Gressier, Elise, Geoghegan, Niall D., Wilcox, Stephen, Rogers, Kelly L., Garnham, Alexandra L., Dengler, Michael A., Bader, Stefanie M., Ebert, Gregor, Pearson, Jaclyn S., De Nardo, Dominic, Wang, Nancy, and Yang, Chenying
- Subjects
- *
CELL death , *APOPTOSIS , *SALMONELLA diseases , *CELL anatomy , *INFECTION control - Abstract
Programmed cell death contributes to host defense against pathogens. To investigate the relative importance of pyroptosis, necroptosis, and apoptosis during Salmonella infection, we infected mice and macrophages deficient for diverse combinations of caspases-1, -11, -12, and -8 and receptor interacting serine/threonine kinase 3 (RIPK3). Loss of pyroptosis, caspase-8-driven apoptosis, or necroptosis had minor impact on Salmonella control. However, combined deficiency of these cell death pathways caused loss of bacterial control in mice and their macrophages, demonstrating that host defense can employ varying components of several cell death pathways to limit intracellular infections. This flexible use of distinct cell death pathways involved extensive cross-talk between initiators and effectors of pyroptosis and apoptosis, where initiator caspases-1 and -8 also functioned as executioners when all known effectors of cell death were absent. These findings uncover a highly coordinated and flexible cell death system with in-built fail-safe processes that protect the host from intracellular infections. • Mice lacking pyroptosis and apoptosis cannot control Salmonella infection • Macrophages lacking pyroptosis and apoptosis resist Salmonella -induced killing • Caspase-1 kills Salmonella -infected cells by activating GSDMD, BID, or other caspases • Caspase-1 and -8 act as cell death executioners when all cell death effectors are lost The clearance of intracellular pathogens requires the killing of infected cells, but it remains unclear why host cells have so many different means of inducing programmed cell death. Doerflinger et al. demonstrate that interconnectivity between pyroptosis and apoptosis involving flexible deployment of caspases ensures control of Salmonella infection in mice. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
38. Speaking the host language: how Salmonella effector proteins manipulate the host.
- Author
-
Pillay TD, Hettiarachchi SU, Gan J, Diaz-Del-Olmo I, Yu XJ, Muench JH, Thurston TLM, and Pearson JS
- Subjects
- Bacteria metabolism, Type III Secretion Systems metabolism, Virulence Factors metabolism, Host-Pathogen Interactions, Bacterial Proteins genetics, Bacterial Proteins metabolism, Salmonella metabolism
- Abstract
Salmonella injects over 40 virulence factors, termed effectors, into host cells to subvert diverse host cellular processes. Of these 40 Salmonella effectors, at least 25 have been described as mediating eukaryotic-like, biochemical post-translational modifications (PTMs) of host proteins, altering the outcome of infection. The downstream changes mediated by an effector's enzymatic activity range from highly specific to multifunctional, and altogether their combined action impacts the function of an impressive array of host cellular processes, including signal transduction, membrane trafficking, and both innate and adaptive immune responses. Salmonella and related Gram-negative pathogens have been a rich resource for the discovery of unique enzymatic activities, expanding our understanding of host signalling networks, bacterial pathogenesis as well as basic biochemistry. In this review, we provide an up-to-date assessment of host manipulation mediated by the Salmonella type III secretion system injectosome, exploring the cellular effects of diverse effector activities with a particular focus on PTMs and the implications for infection outcomes. We also highlight activities and functions of numerous effectors that remain poorly characterized.
- Published
- 2023
- Full Text
- View/download PDF
39. Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death.
- Author
-
Liu L, Sandow JJ, Leslie Pedrioli DM, Samson AL, Silke N, Kratina T, Ambrose RL, Doerflinger M, Hu Z, Morrish E, Chau D, Kueh AJ, Fitzibbon C, Pellegrini M, Pearson JS, Hottiger MO, Webb AI, Lalaoui N, and Silke J
- Abstract
Tumor necrosis factor (TNF) is a key component of the innate immune response. Upon binding to its receptor, TNFR1, it promotes production of other cytokines via a membrane-bound complex 1 or induces cell death via a cytosolic complex 2. To understand how TNF-induced cell death is regulated, we performed mass spectrometry of complex 2 and identified tankyrase-1 as a native component that, upon a death stimulus, mediates complex 2 poly-ADP-ribosylation (PARylation). PARylation promotes recruitment of the E3 ligase RNF146, resulting in proteasomal degradation of complex 2, thereby limiting cell death. Expression of the ADP-ribose-binding/hydrolyzing severe acute respiratory syndrome coronavirus 2 macrodomain sensitizes cells to TNF-induced death via abolishing complex 2 PARylation. This suggests that disruption of ADP-ribosylation during an infection can prime a cell to retaliate with an inflammatory cell death.
- Published
- 2022
- Full Text
- View/download PDF
40. Salmonella Effectors SseK1 and SseK3 Target Death Domain Proteins in the TNF and TRAIL Signaling Pathways.
- Author
-
Newson JPM, Scott NE, Yeuk Wah Chung I, Wong Fok Lung T, Giogha C, Gan J, Wang N, Strugnell RA, Brown NF, Cygler M, Pearson JS, and Hartland EL
- Subjects
- Acetylglucosamine metabolism, Animals, Bacterial Proteins chemistry, Conserved Sequence, Glutamic Acid metabolism, Glycosylation, HEK293 Cells, HeLa Cells, Humans, Mice, Mice, Inbred C57BL, Mutagenesis, Mutation genetics, Protein Domains, RAW 264.7 Cells, Receptors, TNF-Related Apoptosis-Inducing Ligand metabolism, Receptors, Tumor Necrosis Factor, Type I metabolism, Substrate Specificity, TNF Receptor-Associated Death Domain Protein chemistry, TNF Receptor-Associated Death Domain Protein metabolism, Bacterial Proteins metabolism, Salmonella metabolism, Signal Transduction, TNF-Related Apoptosis-Inducing Ligand metabolism, Tumor Necrosis Factor-alpha metabolism
- Abstract
Strains of Salmonella utilize two distinct type three secretion systems to deliver effector proteins directly into host cells. The Salmonella effectors SseK1 and SseK3 are arginine glycosyltransferases that modify mammalian death domain containing proteins with N -acetyl glucosamine (GlcNAc) when overexpressed ectopically or as recombinant protein fusions. Here, we combined Arg-GlcNAc glycopeptide immunoprecipitation and mass spectrometry to identify host proteins GlcNAcylated by endogenous levels of SseK1 and SseK3 during Salmonella infection. We observed that SseK1 modified the mammalian signaling protein TRADD, but not FADD as previously reported. Overexpression of SseK1 greatly broadened substrate specificity, whereas ectopic co-expression of SseK1 and TRADD increased the range of modified arginine residues within the death domain of TRADD. In contrast, endogenous levels of SseK3 resulted in modification of the death domains of receptors of the mammalian TNF superfamily, TNFR1 and TRAILR, at residues Arg
376 and Arg293 respectively. Structural studies on SseK3 showed that the enzyme displays a classic GT-A glycosyltransferase fold and binds UDP-GlcNAc in a narrow and deep cleft with the GlcNAc facing the surface. Together our data suggest that salmonellae carrying sseK1 and sseK3 employ the glycosyltransferase effectors to antagonise different components of death receptor signaling., (© 2019 Newson et al.)- Published
- 2019
- Full Text
- View/download PDF
41. Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli.
- Author
-
Pollock GL, Oates CVL, Giogha C, Wong Fok Lung T, Ong SY, Pearson JS, and Hartland EL
- Subjects
- Caspases metabolism, Cell Line, Ectopic Gene Expression, Escherichia coli Proteins genetics, Fas Ligand Protein metabolism, Genetic Complementation Test, HEK293 Cells, HeLa Cells, Humans, Mutation, Signal Transduction, Virulence Factors genetics, fas Receptor metabolism, Apoptosis, Enteropathogenic Escherichia coli physiology, Escherichia coli Infections metabolism, Escherichia coli Infections microbiology, Escherichia coli Proteins metabolism, Virulence Factors metabolism
- Abstract
During infection, enteropathogenic Escherichia coli (EPEC) translocates effector proteins directly into the cytosol of infected enterocytes using a type III secretion system (T3SS). Once inside the host cell, these effector proteins subvert various immune signaling pathways, including death receptor-induced apoptosis. One such effector protein is the non-locus of enterocyte effacement (LEE)-encoded effector NleB1, which inhibits extrinsic apoptotic signaling via the FAS death receptor. NleB1 transfers a single N -acetylglucosamine (GlcNAc) residue to Arg
117 in the death domain of Fas-associated protein with death domain (FADD) and inhibits FAS ligand (FasL)-stimulated caspase-8 cleavage. Another effector secreted by the T3SS is NleF. Previous studies have shown that NleF binds to and inhibits the activity of caspase-4, -8, and -9 in vitro Here, we investigated a role for NleF in the inhibition of FAS signaling and apoptosis during EPEC infection. We show that NleF prevents the cleavage of caspase-8, caspase-3, and receptor-interacting serine/threonine protein kinase 1 (RIPK1) in response to FasL stimulation. When translocated into host cells by the T3SS or expressed ectopically, NleF also blocked FasL-induced cell death. Using the EPEC-like mouse pathogen Citrobacter rodentium , we found that NleB but not NleF contributed to colonization of mice in the intestine. Hence, despite their shared ability to block FasL/FAS signaling, NleB and NleF have distinct roles during infection., (Copyright © 2017 American Society for Microbiology.)- Published
- 2017
- Full Text
- View/download PDF
42. Erratum: EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.
- Author
-
Pearson JS, Giogha C, Mühlen S, Nachbur U, Pham CL, Zhang Y, Hildebrand JM, Oates CV, Lung TW, Ingle D, Dagley LF, Bankovacki A, Petrie EJ, Schroeder GN, Crepin VF, Frankel G, Masters SL, Vince J, Murphy JM, Sunde M, Webb AI, Silke J, and Hartland EL
- Published
- 2017
- Full Text
- View/download PDF
43. The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNK.
- Author
-
Creuzburg K, Giogha C, Wong Fok Lung T, Scott NE, Mühlen S, Hartland EL, and Pearson JS
- Subjects
- Amino Acid Sequence, Arginine metabolism, Cell Line, Cytokines biosynthesis, Escherichia coli Proteins chemistry, Escherichia coli Proteins genetics, Humans, Mutagenesis, Insertional, Proteolysis, Signal Transduction, Enteropathogenic Escherichia coli physiology, Escherichia coli Infections metabolism, Escherichia coli Infections microbiology, Escherichia coli Proteins metabolism, Host-Pathogen Interactions, JNK Mitogen-Activated Protein Kinases metabolism, p38 Mitogen-Activated Protein Kinases metabolism
- Abstract
Enteropathogenic Escherichia coli (EPEC) is a gastrointestinal pathogen that utilizes a type III secretion system (T3SS) to inject an array of virulence effector proteins into host enterocytes to subvert numerous cellular processes for successful colonization and dissemination. The T3SS effector NleD is a 26-kDa zinc metalloprotease that is translocated into host enterocytes, where it directly cleaves and inactivates the mitogen-activated protein kinase signaling proteins JNK and p38. Here a library of 91 random transposon-based, in-frame, linker insertion mutants of NleD were tested for their ability to cleave JNK and p38 during transient transfection of cultured epithelial cells. Immunoblot analysis of p38 and JNK cleavage showed that 7 mutant derivatives of NleD no longer cleaved p38 but maintained the ability to cleave JNK. Site-directed mutation of specific regions surrounding the insertion sites within NleD revealed that a single amino acid, R203, was essential for cleavage of p38 but not JNK in a direct in vitro cleavage assay, in transiently transfected cells, or in EPEC-infected cells. Mass spectrometry analysis narrowed the cleavage region to within residues 187 and 213 of p38. Mutation of residue R203 within NleD to a glutamate residue abolished the cleavage of p38 and impaired the ability of NleD to inhibit AP-1-dependent gene transcription of a luciferase reporter. Furthermore, the R203 mutation abrogated the ability of NleD to dampen interleukin-6 production in EPEC-infected cells. Overall, this work provides greater insight into substrate recognition and specificity by the type III effector NleD., (Copyright © 2017 American Society for Microbiology.)
- Published
- 2017
- Full Text
- View/download PDF
44. EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.
- Author
-
Pearson JS, Giogha C, Mühlen S, Nachbur U, Pham CL, Zhang Y, Hildebrand JM, Oates CV, Lung TW, Ingle D, Dagley LF, Bankovacki A, Petrie EJ, Schroeder GN, Crepin VF, Frankel G, Masters SL, Vince J, Murphy JM, Sunde M, Webb AI, Silke J, and Hartland EL
- Subjects
- Animals, Cell Death, Citrobacter rodentium pathogenicity, Cysteine Proteases metabolism, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Enteropathogenic Escherichia coli enzymology, Enteropathogenic Escherichia coli metabolism, Escherichia coli Proteins genetics, HEK293 Cells, Humans, Lipopolysaccharides pharmacology, Mice, Phosphorylation, Receptor-Interacting Protein Serine-Threonine Kinases genetics, Signal Transduction drug effects, Tumor Necrosis Factor-alpha metabolism, Type III Secretion Systems, Apoptosis, Escherichia coli Proteins metabolism, Inflammation, Necrosis, Receptor-Interacting Protein Serine-Threonine Kinases metabolism
- Abstract
Cell death signalling pathways contribute to tissue homeostasis and provide innate protection from infection. Adaptor proteins such as receptor-interacting serine/threonine-protein kinase 1 (RIPK1), receptor-interacting serine/threonine-protein kinase 3 (RIPK3), TIR-domain-containing adapter-inducing interferon-β (TRIF) and Z-DNA-binding protein 1 (ZBP1)/DNA-dependent activator of IFN-regulatory factors (DAI) that contain receptor-interacting protein (RIP) homotypic interaction motifs (RHIM) play a key role in cell death and inflammatory signalling
1-3 . RHIM-dependent interactions help drive a caspase-independent form of cell death termed necroptosis4,5 . Here, we report that the bacterial pathogen enteropathogenic Escherichia coli (EPEC) uses the type III secretion system (T3SS) effector EspL to degrade the RHIM-containing proteins RIPK1, RIPK3, TRIF and ZBP1/DAI during infection. This requires a previously unrecognized tripartite cysteine protease motif in EspL (Cys47, His131, Asp153) that cleaves within the RHIM of these proteins. Bacterial infection and/or ectopic expression of EspL leads to rapid inactivation of RIPK1, RIPK3, TRIF and ZBP1/DAI and inhibition of tumour necrosis factor (TNF), lipopolysaccharide or polyinosinic:polycytidylic acid (poly(I:C))-induced necroptosis and inflammatory signalling. Furthermore, EPEC infection inhibits TNF-induced phosphorylation and plasma membrane localization of mixed lineage kinase domain-like pseudokinase (MLKL). In vivo, EspL cysteine protease activity contributes to persistent colonization of mice by the EPEC-like mouse pathogen Citrobacter rodentium. The activity of EspL defines a family of T3SS cysteine protease effectors found in a range of bacteria and reveals a mechanism by which gastrointestinal pathogens directly target RHIM-dependent inflammatory and necroptotic signalling pathways.- Published
- 2017
- Full Text
- View/download PDF
45. Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ.
- Author
-
Zhang Y, Mühlen S, Oates CV, Pearson JS, and Hartland EL
- Subjects
- Adaptor Proteins, Signal Transducing genetics, Amino Acid Motifs, DNA Helicases genetics, Dysentery, Bacillary genetics, Enteropathogenic Escherichia coli genetics, Escherichia coli Infections genetics, HeLa Cells, Humans, Intracellular Signaling Peptides and Proteins genetics, Protein Binding, Shigella flexneri genetics, Adaptor Proteins, Signal Transducing metabolism, DNA Helicases metabolism, Dysentery, Bacillary metabolism, Enteropathogenic Escherichia coli metabolism, Escherichia coli Infections metabolism, Escherichia coli Proteins metabolism, Intracellular Signaling Peptides and Proteins metabolism, Shigella flexneri metabolism, Virulence Factors metabolism
- Abstract
The type III secretion system effector protein NleE from enteropathogenic Escherichia coli plays a key role in the inhibition of NF-κB activation during infection. NleE inactivates the ubiquitin chain binding activity of host proteins TAK1-binding proteins 2 and 3 (TAB2 and TAB3) by modifying the Npl4 zinc finger domain through S-adenosyl methionine-dependent cysteine methylation. Using yeast two-hybrid protein interaction studies, we found that a conserved region between amino acids 34 and 52 of NleE, in particular the motif (49)GITR(52), was critical for TAB2 and TAB3 binding. NleE mutants lacking (49)GITR(52) were unable to methylate TAB3, and wild type NleE but not NleE(49AAAA52) where each of GITR was replaced with alanine restored the ability of an nleE mutant to inhibit IL-8 production during infection. Another NleE target, ZRANB3, also associated with NleE through the (49)GITR(52) motif. Ectopic expression of an N-terminal fragment of NleE (NleE(34-52)) in HeLa cells showed competitive inhibition of wild type NleE in the suppression of IL-8 secretion during enteropathogenic E. coli infection. Similar results were observed for the NleE homologue OspZ from Shigella flexneri 6 that also bound TAB3 through the (49)GITR(52) motif and decreased IL-8 transcription through modification of TAB3. In summary, we have identified a unique substrate-binding motif in NleE and OspZ that is required for the ability to inhibit the host inflammatory response., (© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
46. Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.
- Author
-
Wong Fok Lung T, Giogha C, Creuzburg K, Ong SY, Pollock GL, Zhang Y, Fung KY, Pearson JS, and Hartland EL
- Subjects
- Animals, Apoptosis, Arginine metabolism, Citrobacter rodentium genetics, Citrobacter rodentium pathogenicity, DNA Transposable Elements, Enterobacteriaceae Infections microbiology, Enterobacteriaceae Infections pathology, Fas Ligand Protein metabolism, Fas-Associated Death Domain Protein metabolism, Female, Humans, Mice, Inbred C57BL, Mutagenesis, Insertional, Mutagenesis, Site-Directed, Protein Processing, Post-Translational, Virulence, DNA Mutational Analysis, Enteropathogenic Escherichia coli enzymology, Enteropathogenic Escherichia coli pathogenicity, Escherichia coli Proteins genetics, Escherichia coli Proteins metabolism, Glycosyltransferases genetics, Glycosyltransferases metabolism, Virulence Factors genetics, Virulence Factors metabolism
- Abstract
Enteropathogenic Escherichia coli (EPEC) interferes with host cell signaling by injecting virulence effector proteins into enterocytes via a type III secretion system (T3SS). NleB1 is a novel T3SS glycosyltransferase effector from EPEC that transfers a single N-acetylglucosamine (GlcNAc) moiety in an N-glycosidic linkage to Arg(117) of the Fas-associated death domain protein (FADD). GlcNAcylation of FADD prevents the assembly of the canonical death-inducing signaling complex and inhibits Fas ligand (FasL)-induced cell death. Apart from the DXD catalytic motif of NleB1, little is known about other functional sites in the enzyme. In the present study, members of a library of 22 random transposon-based, in-frame, linker insertion mutants of NleB1 were tested for their ability to block caspase-8 activation in response to FasL during EPEC infection. Immunoblot analysis of caspase-8 cleavage showed that 17 mutant derivatives of NleB1, including the catalytic DXD mutant, did not inhibit caspase-8 activation. Regions of interest around the insertion sites with multiple or single amino acid substitutions were examined further. Coimmunoprecipitation studies of 34 site-directed mutants showed that the NleB1 derivatives with the E253A, Y219A, and PILN(63-66)AAAA (in which the PILN motif from residues 63 to 66 was changed to AAAA) mutations bound to but did not GlcNAcylate FADD. A further mutant derivative, the PDG(236-238)AAA mutant, did not bind to or GlcNAcylate FADD. Infection of mice with the EPEC-like mouse pathogen Citrobacter rodentium expressing NleBE253A and NleBY219A showed that these strains were attenuated, indicating the importance of residues E253 and Y219 in NleB1 virulence in vivo In summary, we identified new amino acid residues critical for NleB1 activity and confirmed that these are required for the virulence function of NleB1., (Copyright © 2016, American Society for Microbiology. All Rights Reserved.)
- Published
- 2016
- Full Text
- View/download PDF
47. Substrate recognition by the zinc metalloprotease effector NleC from enteropathogenic Escherichia coli.
- Author
-
Giogha C, Lung TW, Mühlen S, Pearson JS, and Hartland EL
- Subjects
- Amino Acid Motifs, DNA Mutational Analysis, Protein Binding, Protein Structure, Tertiary, Proteolysis, Transcription Factor RelA genetics, Enteropathogenic Escherichia coli enzymology, Escherichia coli Proteins metabolism, Metalloproteases metabolism, Transcription Factor RelA metabolism
- Abstract
Upon infection of epithelial cells, enteropathogenic Escherichia coli suppresses host cell inflammatory signalling in a type III secretion system (T3SS) dependent manner. Two key T3SS effector proteins involved in this response are NleE and NleC. NleC is a zinc metalloprotease effector that degrades the p65 subunit of NF-κB. Although the site of p65 cleavage by NleC is now well described, other areas of interaction have not been precisely defined. Here we constructed overlapping truncations of p65 to identify regions required for NleC cleavage. We determined that NleC cleaved both p65 and p50 within the Rel homology domain (RHD) and that two motifs, E22IIE25 and P177VLS180 , within the RHD of p65 were important for recognition and binding by NleC. Alanine substitution of one or both of these motifs protected p65 from binding and degradation by NleC. The E22IIE25 and P177VLS180 motifs were located within the structurally distinct N-terminal subdomain of the RHD involved in DNA binding by p65 on adjacent, parallel strands. Although these motifs have not been recognized previously, both were needed for the correct localization and function of p65. In summary, this work has identified two regions of p65 within the RHD needed for binding and cleavage by NleC and provides further insight into the molecular basis of substrate recognition by a T3SS effector., (© 2015 John Wiley & Sons Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
48. The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.
- Author
-
Pallett MA, Berger CN, Pearson JS, Hartland EL, and Frankel G
- Subjects
- Caspases genetics, Caspases metabolism, Enteropathogenic Escherichia coli genetics, Escherichia coli Proteins genetics, HeLa Cells, Humans, Interleukin-8 genetics, Interleukin-8 metabolism, Mitochondria, NF-kappa B genetics, RNA, Messenger genetics, RNA, Messenger metabolism, Up-Regulation, Virulence Factors genetics, Enteropathogenic Escherichia coli metabolism, Escherichia coli Proteins metabolism, Gene Expression Regulation immunology, NF-kappa B metabolism, Virulence Factors metabolism
- Abstract
The enteric pathogens enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli employ a type 3 secretion system (T3SS) to manipulate the host inflammatory response during infection. Previously, it has been reported that EPEC, in a T3SS-dependent manner, induces an early proinflammatory response through activation of NF-κB via extracellular signal-regulated kinases 1 and 2 (ERK1/2) and protein kinase Cζ (PKCζ). However, the activation of NF-κB during infection has not yet been attributed to an effector. At later time points postinfection, NF-κB signaling is inhibited through the translocation of multiple effectors, including NleE and NleC. Here we report that the highly conserved non-LEE (locus of enterocyte effacement)-encoded effector F (NleF) shows both diffuse and mitochondrial localization during ectopic expression. Moreover, NleF induces the nuclear translocation of NF-κB p65 and the expression of interleukin 8 (IL-8) following ectopic expression and during EPEC infection. Furthermore, the proinflammatory activity and localization of NleF were dependent on the C-terminal amino acids LQCG. While the C-terminal domain of NleF has previously been shown to be essential for interaction with caspase-4, caspase-8, and caspase-9, the proinflammatory activity of NleF was independent of interaction with caspase-4, -8, or -9. In conclusion, EPEC, through the T3SS-dependent translocation of NleF, induces a proinflammatory response in an NF-κB-dependent manner in the early stages of infection., (Copyright © 2014, American Society for Microbiology. All Rights Reserved.)
- Published
- 2014
- Full Text
- View/download PDF
49. The Inflammatory Response during Enterohemorrhagic Escherichia coli Infection.
- Author
-
Pearson JS and Hartland EL
- Subjects
- Humans, Enterohemorrhagic Escherichia coli immunology, Epithelial Cells immunology, Epithelial Cells microbiology, Escherichia coli Infections immunology, Escherichia coli Infections pathology, Host-Pathogen Interactions, Inflammation pathology
- Abstract
The inflammatory response is an integral part of host defense against enterohemorrhagic Escherichia coli (EHEC) infection and also contributes to disease pathology. In this article we explore the factors leading to inflammation during EHEC infection and the mechanisms EHEC and other attaching and effacing (A/E) pathogens have evolved to suppress inflammatory signaling. EHEC stimulates an inflammatory response in the intestine through host recognition of bacterial components such as flagellin and lipopolysaccharide. In addition, the activity of Shiga toxin and some type III secretion system effectors leads to increased tissue inflammation. Various infection models of EHEC and other A/E pathogens have revealed many of the immune factors that mediate this response. In particular, the outcome of infection is greatly influenced by the ability of an infected epithelial cell to mount an effective host inflammatory response. The inflammatory response of infected enterocytes is counterbalanced by the activity of type III secretion system effectors such as NleE and NleC that modify and inhibit components of the signaling pathways that lead to proinflammatory cytokine production. Overall, A/E pathogens have taught us that innate mucosal immune responses in the gastrointestinal tract during infection with A/E pathogens are highly complex and ultimate clearance of the pathogen depends on multiple factors, including inflammatory mediators, bacterial burden, and the function and integrity of resident intestinal epithelial cells.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.